Paper39235486
Pharmacology of Non-Psychoactive Phytocannabinoids and Their Potential for Treatment of Cardiometabolic Disease.
Wainwright CL and 1 other. Handb Exp Pharmacol, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Pharmacology of Non-Psychoactive Phytocannabinoids and Their Potential for Treatment of Cardiometabolic Disease. Papers, record 39235486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39235486
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacology of Non-Psychoactive Phytocannabinoids and Their Potential for Treatment of Cardiometabolic Disease.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cannabinoids | Major topic |
| Cardiovascular Diseases | Major topic |
| Metabolic Diseases | Major topic |
| Humans | |
| Animals | |
| Cannabis |
Source PubMed
References199
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18234885 | Cannabinoids desensitize capsaicin and mustard oil responses in sensory neurons via TRPA1 activation. | J Neurosci | 2008 | https://conductscience.org/library/papers/18234885 | PubMed |
| 2 | 37074505 | Cardioprotective role of a magnolol and honokiol complex in the prevention of doxorubicin-mediated cardiotoxicity in adult rats. | Mol Cell Biochem | 2024 | https://conductscience.org/library/papers/37074505 | PubMed |
| 3 | 28368293 | (-)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28368293 | PubMed |
| 4 | 23891880 | Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy. | Drug Discov Today | 2014 | https://conductscience.org/library/papers/23891880 | PubMed |
| 5 | 25711828 | Effects of cannabidiol on contractions and calcium signaling in rat ventricular myocytes. | Cell Calcium | 2015 | https://conductscience.org/library/papers/25711828 | PubMed |
| 6 | 20621717 | Cannabidiol injected into the bed nucleus of the stria terminalis modulates baroreflex activity through 5-HT1A receptors. | Pharmacol Res | 2010 | https://conductscience.org/library/papers/20621717 | PubMed |
| 7 | 22027819 | Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22027819 | PubMed |
| 8 | 34223660 | A placebo-controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans. | Br J Clin Pharmacol | 2022 | https://conductscience.org/library/papers/34223660 | PubMed |
| 9 | 34290671 | An Autonomous Cannabinoid System in Islets of Langerhans. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/34290671 | PubMed |
| 10 | 35489272 | Combination of 1,8-cineole and beta-caryophyllene synergistically reverses cardiac hypertrophy in isoprenaline-induced mice and H9c2 cells. | Bioorg Chem | 2022 | https://conductscience.org/library/papers/35489272 | PubMed |
| 11 | 31800399 | Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: modification by hypertension and the potential pharmacological opportunities. | J Hypertens | 2020 | https://conductscience.org/library/papers/31800399 | PubMed |
| 12 | 15451779 | Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. | Circulation | 2004 | https://conductscience.org/library/papers/15451779 | PubMed |
| 13 | 12644592 | The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. | Mol Pharmacol | 2003 | https://conductscience.org/library/papers/12644592 | PubMed |
| 14 | 32194509 | Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/32194509 | PubMed |
| 15 | 11606325 | Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. | Br J Pharmacol | 2001 | https://conductscience.org/library/papers/11606325 | PubMed |
| 16 | 17065342 | Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. | Diabetes | 2006 | https://conductscience.org/library/papers/17065342 | PubMed |
| 17 | 31332735 | Cannabinoids and Cardiovascular System. | Adv Exp Med Biol | 2019 | https://conductscience.org/library/papers/31332735 | PubMed |
| 18 | 19919870 | Cannabinoid CB1 receptor expression in relation to visceral adipose depots, endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G variant in humans. | Metabolism | 2010 | https://conductscience.org/library/papers/19919870 | PubMed |
| 19 | 33221931 | Cannabidiol: pharmacology and therapeutic targets. | Psychopharmacology (Berl) | 2021 | https://conductscience.org/library/papers/33221931 | PubMed |
| 20 | 28720829 | Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis. | Sci Rep | 2017 | https://conductscience.org/library/papers/28720829 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39235486
GET https://conductscience.org/api/papers/v1/39235486/references?page=2